The McQuade Center for Strategic Research and Development collaborates with Eikonizo Therapeutics


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ The McQuade Center for Strategic Research and Development collaborates with Eikonizo Therapeutics
The McQuade Center for Strategic Research and Development and Eikonizo Therapeutics enter agreement to develop treatments for patients with are diseases

The McQuade Center for Strategic Research and Development, LLC (MSRD), a member of the global Otsuka family of pharmaceutical companies, announces it has entered a collaboration agreement with Eikonizo Therapeutics, Inc., a biotechnology company committed to creating life-changing therapies, to develop inhibitors of histone deacetylase-6 (HDAC6) focused on treating amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease, and other diseases.

Under the terms of the agreement, MSRD and Eikonizo will collaborate to advance Eikonizo’s HDAC6 inhibitors through preclinical and Phase 1b clinical studies respectively, with the opportunity to expand the collaboration after those studies.

“We are dedicated to seeking out and supporting novel treatments for complex and rare diseases,” said Robert McQuade, Ph.D., president, McQuade Center for Strategic Research and Development, LLC, and chief strategic officer, Otsuka Pharmaceutical Development & Commercialization, Inc. “Based on our pre-clinical evaluation, we are hopeful that Eikonizo’s compounds can open up new treatment options for patients living with ALS and other rare diseases of high unmet need.”

“Eikonizo is discovering and developing novel small molecule therapeutics and leveraging companion target engagement technology to de-risk and accelerate development. We believe our approach and our brain-penetrant HDAC6 inhibitors could provide a transformative therapy for ALS,” said Janice Kranz, PhD., co-founder, CEO and president of Eikonizo. “We are delighted to collaborate with MSRD, honored that they recognize the potential of Eikonizo’s strategy and HDAC6-targeting platform, and excited to leverage MSRD’s experience and support to markedly accelerate development of our first therapeutic candidate into the clinic. Eikonizo and MSRD share values of innovation, scientific rigor and urgency to address unmet medical needs and thus make a meaningful impact on patients’ lives.”

Tags : #TheMcQuadeCenterforStrategicResearchandDevelopment #EikonizoTherapeutics #LatestNewsonEikonizoTherapeutics10thFeb #LatestPharmaNews10thFeb #LatestPharmaCollaboration10thFeb #LouGehrigsdisease

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026